NCT02158572View on ClinicalTrials.gov

Efficacy, Safety and Tolerability Study of Agile AG200-15 Transdermal Contraceptive Delivery System

PHASE3CompletedINTERVENTIONAL
Enrollment

2,032

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Healthy
Interventions
DRUG

AG200-15

Transdermal contraceptive delivery system

Sponsors

Lead Sponsor

Agile Therapeutics
All Listed Sponsors
lead

Agile Therapeutics

INDUSTRY

NCT02158572 - Efficacy, Safety and Tolerability Study of Agile AG200-15 Transdermal Contraceptive Delivery System | Biotech Hunter | Biotech Hunter